[ad_1] Sun Pharmaceuticals Industries Ltd on Thursday, April 10 said the US Court of Appeals for the Federal Circuit has ruled in favour of the company and vacated its preliminary injunction of delaying the launch of Leqselvi (deuruxolitinib), effective immediately. The medication is intended for treating severe alopecia areata. The US Court of Appeals for […]
Why Sun Pharma may be in focus on Monday – CNBC TV18
[ad_1] Sun Pharmaceutical Industries is likely to attract attention on Monday (November 4) following a recent US court ruling that has delayed the launch of its new drug, LEQSELVITM (deuruxolitinib). The US District Court of New Jersey issued a preliminary injunction, which blocks Sun Pharma from introducing the medication, intended for treating severe alopecia areata, […]